Matt, Author at European Medical Journal - Page 104 of 212

This site is intended for healthcare professionals

Continue
12 Mins
29 Jul 2019

Review of the European League Against Rheumatism (EULAR) Congress 2019

This year’s European League Against Rheumatism (EULAR) congress opened with an inspiring presentation from EULAR president Prof Hans Bijlsma and host…
1 Mins
29 Jul 2019

Efficacy and Safety of E6011, an Anti-Fractalkine Monoclonal Antibody, in MTX-IR Patients with Rheumatoid Arthritis

Fractalkine (CX3CL1, designated as FKN hereafter) is the sole member of the CX3C chemokine family which leads to dual actions, chemotaxis, and cell…
2 Mins
29 Jul 2019

Comparative Effectiveness Research in Observational Settings: Evaluating Two New Methods to Analyse Response Rates

Observational studies are being used more frequently to compare drug effectiveness. Authors typically report the proportion of patients…
9 Mins
29 Jul 2019

Considering the Patient Perspective: Challenges Facing Women with Axial Spondyloarthritis and Psoriatic Arthritis

Although gender is defined by psychological and social differences between men and women, and sex is defined by biological parameters based on genetics…
6 Mins
29 Jul 2019

EULAR 2019: Meet the Editorial Board

EULAR is much bigger than other congresses and meetings I usually attend, which are mostly at a national level. The science on offer is very broad…
2 Mins
29 Jul 2019

Circulating T Cell Clones in Preclinical Phases of Rheumatoid Arthritis

The aetiopathogenesis of rheumatoid arthritis (RA) is only partially understood, but is believed to result from a multi-step process, whereby…
5 Mins
29 Jul 2019

EULAR 2019 Interview: Meet the Organisers

Each year, the EULAR congress continues to grow larger and larger. Ensuring an exciting and fulfilling programme is an enormous undertaking…
11 Mins
29 Jul 2019

Metacognition in Rheumatoid Arthritis: Thinking About Our Thinking in Rheumatoid Arthritis Management

Since the 1990s, outcomes for patients with RA have steadily improved over time, with the treatment target for patients evolving from symptomatic relief…
1 Mins
29 Jul 2019

Comparison of PAXgene and Tempus Whole Blood RNA Collection and Isolation Systems for the Quantification of Type I Interferon-Stimulated Gene Expression

Type I IFN have important roles in many paediatric and adult rheumatic diseases and are a new therapeutic target for which several anti-IFN treatments…
10 Mins
29 Jul 2019

Fine-Tuning the Treatment of Psoriatic Arthritis: Focus on the IL-23 Pathway

The aim of this symposium was to familiarise participants with the IL-23 pathway and the rationale for targeting this pathway in PsA…
We’ve noticed you’re accessing
from North/South America.